Department of Psychiatry (Huang, Ceceli, Kronberg, Malaker, Parvaz, Alia-Klein, Goldstein) and Department of Neuroscience, Friedman Brain Institute (King, Parvaz, Alia-Klein, Goldstein), Icahn School of Medicine at Mount Sinai, New York; Center on Mindfulness and Integrative Health Intervention Development and College of Social Work, University of Utah, Salt Lake City (Garland).
Am J Psychiatry. 2024 Feb 1;181(2):153-165. doi: 10.1176/appi.ajp.20220759. Epub 2023 Jul 12.
The authors investigated cortico-striatal reactivity to drug cues (as compared with neutral and food cues), drug cue reappraisal, food cue savoring, and their correlations with heroin craving in individuals with heroin use disorder compared with healthy control subjects.
Cross-sectional changes in functional MRI blood-oxygen-level-dependent signal during a novel cue reactivity task were assessed in 32 individuals with heroin use disorder (mean age, 40.3 years; seven women) and 21 age- and sex-matched healthy control subjects (mean age, 40.6 years; eight women).
Drug cue reactivity (vs. neutral cues) was significantly higher in the nucleus accumbens in the heroin use disorder group compared with the control group and nominally significantly higher in the orbitofrontal cortex (OFC); ventromedial prefrontal cortex (vmPFC) activity positively correlated with drug craving. Drug cue reactivity (vs. salient food cues) was also higher in the inferior frontal gyrus (IFG) in the heroin use disorder group compared with the control group. Drug reappraisal and food savoring (vs. passive viewing) showed increased IFG and supplementary motor area activity in all participants; in the heroin use disorder group, higher IFG/dorsolateral PFC (dlPFC) activity during drug reappraisal and rostral anterior cingulate cortex (ACC) activity during food savoring were associated with lower drug cue-induced craving and longer treatment, respectively. A direct comparison of regulation of reactivity to both salient cues revealed widespread group differences such that drug reappraisal activity was higher in the heroin use disorder group and food savoring activity was higher in the control group in both cortical (e.g., OFC, IFG, ACC, vmPFC, and insula) and subcortical (e.g., dorsal striatum and hippocampus) regions. Higher drug reappraisal versus food savoring in the dlPFC was associated with higher self-reported methadone dosage in the heroin use disorder group.
The results demonstrate cortico-striatal upregulation during drug cue exposure and impaired reactivity during processing of alternative non-drug rewards in the heroin use disorder group. Normalizing cortico-striatal function by reducing drug cue reactivity and enhancing natural reward valuation may inform therapeutic mechanisms for reducing drug craving and seeking in heroin addiction.
作者研究了皮质纹状体对药物线索(与中性和食物线索相比)的反应性,药物线索再评价,食物线索享受,以及它们与海洛因使用障碍个体与健康对照组相比的海洛因渴望之间的相关性。
在一项新的线索反应性任务中,评估了 32 名海洛因使用障碍个体(平均年龄 40.3 岁,7 名女性)和 21 名年龄和性别匹配的健康对照组个体(平均年龄 40.6 岁,8 名女性)的功能磁共振成像血液氧水平依赖性信号的横断面变化。
与对照组相比,海洛因使用障碍组的伏隔核中药物线索反应性(与中性线索相比)显著升高,眶额皮层(OFC)中药物线索反应性略有升高;腹内侧前额叶皮层(vmPFC)的活动与药物渴望呈正相关。与对照组相比,海洛因使用障碍组的下额前回(IFG)中药物线索反应性(与显著食物线索相比)也较高。药物再评价和食物享受(与被动观察相比)在所有参与者中均显示出额下回(IFG)和辅助运动区活动增加;在海洛因使用障碍组中,药物再评价时 IFG/背外侧前额叶皮层(dlPFC)活动较高,食物享受时前扣带皮层(ACC)活动较高,分别与较低的药物线索诱发的渴望和较长的治疗时间相关。对两种显著线索的反应性调节的直接比较显示出广泛的群体差异,例如在海洛因使用障碍组中,药物再评价的活动更高,而在对照组中,在皮质(例如,OFC、IFG、ACC、vmPFC 和岛叶)和皮质下(例如,背侧纹状体和海马)区域中,食物享受的活动更高。在 dlPFC 中,药物再评价与食物享受相比更高,与海洛因使用障碍组中自我报告的美沙酮剂量更高相关。
结果表明,在海洛因使用障碍组中,药物线索暴露期间皮质纹状体上调,替代非药物奖励处理期间反应性受损。通过降低药物线索反应性和增强自然奖励评估来使皮质纹状体功能正常化,可能为减少海洛因成瘾中的药物渴望和寻求提供治疗机制。